Several ASX shares rose well over 4% yesterday. This includes Cimic Group Ltd (ASX: CIM), up 8%, and Dicker Data Ltd (ASX: DDR), up 6.85%. However, it was the movement of two acknowledged growth shares that caught my attention.
Image source: Getty Images
Pro Medicus Limited (ASX: PME)
This ASX share price leapt by 6.66% after signing a $10 million deal with a Munich-based university. Ludwig-Maximilians-Universität (LMU Klinikum) is one of the largest university hospitals in Germany. Consequently, the deal will see the Pro Medicus technology, Visage, deployed throughout LMU Klinikum's radiology and subspecialty imaging departments. Thus replacing systems from legacy vendors.
"We look forward to taking our partnership with Visage to the next level as we implement their technology across our radiology department," said Dr Kurt Kruber, CIO of LMU Klinikum. "The Visage platform provides a highly scalable and reliable platform combined with sophisticated clinical features that will support us in both day-to-day patient care and advanced research."
Dr Kurt added that large European teaching hospitals had standardised on IT platforms from large, multinational imaging equipment vendors. This underlines the importance of the deal as a breakthrough for this pioneering ASX share. The Pro Medicus share price has risen by 14.3% in 5 days of trading after announcing another international deal on 15 October.
WiseTech Global Ltd (ASX: WTC)
WiseTech saw its ASX share price rise by 4.43% yesterday. This was after news that company CEO, Richard White, would be selling the corporate headquarters acquired four years ago. This is part of an ongoing commitment by the billionaire CEO to stop doing private business with a public company by the end of 2021.
The property is a sale-and-leaseback deal, with WiseTech as the major tenant on a five-year lease. Moreover, the building was customised to match the requirements of this ASX share.
However, this clarification of interests is not the only tailwind behind WiseTech these days. The company's recent annual report disclosed a 23% increase in revenues compared to FY19 performance. In addition, earnings before interest, taxes, depreciation and amortisation (EDITDA) rose by 17% against FY19.
Despite the impacts of COVID-19, the company sustained very low attrition rates, and reducing the company reliance on its top 10 customers, down 2% from FY19to 20% of revenue. This isolates WiseTech from impacts of losing large clients.
